Stoke Therapeutics, Inc. Announces 2024 Annual Meeting of Stockholders

TL;DR

<b>Stoke Therapeutics will hold its 2024 Annual Meeting of Stockholders virtually on June 5, 2024, encouraging online voting and providing proxy materials via the internet.</b>

AI Summary

Stoke Therapeutics, Inc. (STOK) filed a Proxy Statement (DEF 14A) with the SEC on April 23, 2024. The 2024 Annual Meeting of Stockholders for Stoke Therapeutics, Inc. will be held virtually on June 5, 2024. Stockholders can submit questions and vote online at www.virtualshareholdermeeting.com/STOK2024. The company is furnishing proxy materials to stockholders over the Internet to reduce environmental impact and printing costs. A Notice of Internet Availability of Proxy Materials will be mailed on or about April 23, 2024. Stockholders are encouraged to vote via Internet, telephone, or by returning a proxy card.

Why It Matters

For investors and stakeholders tracking Stoke Therapeutics, Inc., this filing contains several important signals. The shift to a virtual meeting and internet-based proxy material distribution aims to increase accessibility and reduce costs and environmental impact. The company emphasizes the importance of stockholder participation through various voting methods to ensure representation at the meeting.

Risk Assessment

Risk Level: low — Stoke Therapeutics, Inc. shows low risk based on this filing. The filing is a routine DEF 14A proxy statement, indicating standard corporate governance procedures rather than significant new business developments or financial events.

Analyst Insight

Stockholders should review the proxy materials and vote their shares prior to the June 5, 2024 meeting to ensure their voice is heard on corporate matters.

Key Numbers

• June 5, 2024 — Annual Meeting Date (2024 Annual Meeting of Stockholders)
• April 23, 2024 — Notice Mailing Date (Notice of Internet Availability of Proxy Materials)
• 2024 — Meeting Year (2024 Annual Meeting of Stockholders)
• 2023 — Annual Report Year (2023 Annual Report on Form 10-K)

Key Players & Entities

• Stoke Therapeutics, Inc. (company) — Registrant
• June 5, 2024 (date) — Date of Annual Meeting
• www.virtualshareholdermeeting.com/STOK2024 (url) — Virtual Meeting Platform
• April 23, 2024 (date) — Mailing Date of Notice
• 45 WIGGINS AVENUE (address) — Company Business Address
• BEDFORD (location) — Company Business Address City
• MA (location) — Company Business Address State
• 01730 (postal_code) — Company Business Address Zip

FAQ

Key Dates

• 2024-06-05: 2024 Annual Meeting of Stockholders — Key date for stockholder participation and voting.
• 2024-04-23: Mailing of Notice of Internet Availability of Proxy Materials — Indicates when stockholders will receive instructions for accessing proxy materials and voting.

Glossary

DEF 14A

Definitive Proxy Statement filed with the SEC. (This filing type indicates the company is providing official proxy materials to shareholders for an upcoming meeting.)

Proxy Statement

A document containing information that the SEC requires companies to provide to shareholders before their annual meeting. (Essential for shareholders to understand the matters to be voted on and make informed decisions.)

Notice of Internet Availability of Proxy Materials

A document informing shareholders that proxy materials are available online and providing instructions on how to access them. (Used by companies to reduce printing and mailing costs while ensuring shareholders receive necessary information.)

Key Financial Figures

• $1.235 b — total annual gross revenue of at least $1.235 billion, or (b) in which we are deemed to
• $700 million — that is held by non-affiliates exceeds $700 million as of the prior June 30th; and (3) the
• $1.0 billion — date on which we have issued more than $1.0 billion in non-convertible debt during the prio

Filing Documents

• d703012ddef14a.htm (DEF 14A) — 335KB
• g703012g40m34.jpg (GRAPHIC) — 25KB
• g703012g64q82.jpg (GRAPHIC) — 35KB
• g703012g70j10.jpg (GRAPHIC) — 15KB
• g703012g88d89.jpg (GRAPHIC) — 133KB
• g703012g95k09.jpg (GRAPHIC) — 93KB
• 0001193125-24-106979.txt (&nbsp;) — 745KB

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 21 EXECUTIVE OFFICERS 24

EXECUTIVE COMPENSATION

EXECUTIVE COMPENSATION 26 EQUITY COMPENSATION PLAN INFORMATION 32 CERTAIN RELATIONSHIPS AND RELATED-PARTY TRANSACTIONS 33 ADDITIONAL INFORMATION 34 OTHER MATTERS 35 Table of Contents STOKE THERAPEUTICS, INC. 45 Wiggins Avenue Bedford, MA 01730 PROXY June 5, 2024 INFORMATION ABOUT SOLICITATION AND VOTING The accompanying proxy is solicited on behalf of the Board of Directors of Stoke Therapeutics, Inc., (Stoke or the Company), for use at the Companys 2024 Annual Meeting of Stockholders (Annual Meeting) on Wednesday, June 5, 2024 at 9:00 a.m. (Eastern Time), and any adjournment or postponement thereof. To provide greater access to those who may want to attend the Annual Meeting will be held virtually at www.virtualshareholdermeeting.com/STOK2024. It is important that you retain a copy of the 16-digit control number found on the proxy card, voting instruction form or Notice, as such number will be required in order for stockholders to participate in the virtual Annual Meeting. INTERNET AVAILABILITY OF PROXY MATERIALS Under rules adopted by the Securities and Exchange Commission (SEC), we are furnishing proxy materials to our stockholders primarily via the Internet, instead of mailing printed copies to each stockholder. On or about April 23, 2024, we expect to send to our stockholders a Notice of Internet Availability of Proxy Materials (Notice of Internet Availability) containing instructions on how to access our proxy materials, including our proxy statement and our Annual Report on Form 10-K. The Notice of Internet Availability also provides instructions on how to vote and includes instructions on how to receive paper copies of the proxy materials by mail, or an electronic copy of the proxy materials by email. This process is designed to reduce our environmental impact and lower the costs of printing and distributing our proxy materials while providing our stockholders timel

View Full Filing

View this DEF 14A filing on SEC EDGAR